134 related articles for article (PubMed ID: 35038554)
1. Multiplex genome editing of mammalian cells for producing recombinant heparin.
Thacker BE; Thorne KJ; Cartwright C; Park J; Glass K; Chea A; Kellman BP; Lewis NE; Wang Z; Di Nardo A; Sharfstein ST; Jeske W; Walenga J; Hogwood J; Gray E; Mulloy B; Esko JD; Glass CA
Metab Eng; 2022 Mar; 70():155-165. PubMed ID: 35038554
[TBL] [Abstract][Full Text] [Related]
2. ZNF263 is a transcriptional regulator of heparin and heparan sulfate biosynthesis.
Weiss RJ; Spahn PN; Toledo AG; Chiang AWT; Kellman BP; Li J; Benner C; Glass CK; Gordts PLSM; Lewis NE; Esko JD
Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9311-9317. PubMed ID: 32277030
[TBL] [Abstract][Full Text] [Related]
3. Bioengineering murine mastocytoma cells to produce anticoagulant heparin.
Gasimli L; Glass CA; Datta P; Yang B; Li G; Gemmill TR; Baik JY; Sharfstein ST; Esko JD; Linhardt RJ
Glycobiology; 2014 Mar; 24(3):272-80. PubMed ID: 24326668
[TBL] [Abstract][Full Text] [Related]
4. Bioengineered heparins and heparan sulfates.
Fu L; Suflita M; Linhardt RJ
Adv Drug Deliv Rev; 2016 Feb; 97():237-49. PubMed ID: 26555370
[TBL] [Abstract][Full Text] [Related]
5. Heparin induces changes in the synthesis of porcine aortic endothelial cell heparan sulfate proteoglycans.
Morrison P; Lowe-Krentz LJ
Exp Cell Res; 1989 Oct; 184(2):304-15. PubMed ID: 2530099
[TBL] [Abstract][Full Text] [Related]
6. Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?
Farrugia BL; Lord MS; Melrose J; Whitelock JM
Molecules; 2015 Mar; 20(3):4254-76. PubMed ID: 25751786
[TBL] [Abstract][Full Text] [Related]
7. Surprising absence of heparin in the intestinal mucosa of baby pigs.
Yu Y; Chen Y; Mikael P; Zhang F; Stalcup AM; German R; Gould F; Ohlemacher J; Zhang H; Linhardt RJ
Glycobiology; 2017 Jan; 27(1):57-63. PubMed ID: 27744271
[TBL] [Abstract][Full Text] [Related]
8. Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans.
Warda M; Mao W; Toida T; Linhardt RJ
Comp Biochem Physiol B Biochem Mol Biol; 2003 Jan; 134(1):189-97. PubMed ID: 12524047
[TBL] [Abstract][Full Text] [Related]
9. Structure-Activity Relationships of Bioengineered Heparin/Heparan Sulfates Produced in Different Bioreactors.
Kim HN; Whitelock JM; Lord MS
Molecules; 2017 May; 22(5):. PubMed ID: 28505124
[TBL] [Abstract][Full Text] [Related]
10. Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application.
Hu P; Fang L; Chess EK
Anal Chem; 2009 Mar; 81(6):2332-43. PubMed ID: 19228018
[TBL] [Abstract][Full Text] [Related]
11. Strategies in Synthesis of Heparin/Heparan Sulfate Oligosaccharides: 2000-Present.
Dulaney SB; Huang X
Adv Carbohydr Chem Biochem; 2021; 80():121-164. PubMed ID: 34872655
[TBL] [Abstract][Full Text] [Related]
12. Bioengineered human heparin with anticoagulant activity.
Lord MS; Cheng B; Tang F; Lyons JG; Rnjak-Kovacina J; Whitelock JM
Metab Eng; 2016 Nov; 38():105-114. PubMed ID: 27445159
[TBL] [Abstract][Full Text] [Related]
13. Porcine Circovirus 2 Uses a Multitude of Weak Binding Sites To Interact with Heparan Sulfate, and the Interactions Do Not Follow the Symmetry of the Capsid.
Dhindwal S; Avila B; Feng S; Khayat R
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602608
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells.
Nishinaga M; Ozawa T; Shimada K
J Clin Invest; 1993 Sep; 92(3):1381-6. PubMed ID: 8376590
[TBL] [Abstract][Full Text] [Related]
15. Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry.
Naimy H; Leymarie N; Zaia J
Biochemistry; 2010 May; 49(17):3743-52. PubMed ID: 20345121
[TBL] [Abstract][Full Text] [Related]
16. Expression of the mouse mastocytoma glucosaminyl N-deacetylase/ N-sulfotransferase in human kidney 293 cells results in increased N-sulfation of heparan sulfate.
Cheung WF; Eriksson I; Kusche-Gullberg M; Lindhal U; Kjellén L
Biochemistry; 1996 Apr; 35(16):5250-6. PubMed ID: 8611511
[TBL] [Abstract][Full Text] [Related]
17. Isolation of low-molecular-weight heparin/heparan sulfate from marine sources.
Saravanan R
Adv Food Nutr Res; 2014; 72():45-60. PubMed ID: 25081076
[TBL] [Abstract][Full Text] [Related]
18. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
Hovingh P; Piepkorn M; Linker A
Biochem J; 1986 Jul; 237(2):573-81. PubMed ID: 2948492
[TBL] [Abstract][Full Text] [Related]
19. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
[TBL] [Abstract][Full Text] [Related]
20. A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential.
Brito AS; Cavalcante RS; Palhares LC; Hughes AJ; Andrade GP; Yates EA; Nader HB; Lima MA; Chavante SF
Carbohydr Polym; 2014 Jan; 99():372-8. PubMed ID: 24274520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
